The Role Of Vitamin D For Therapy Responses On Drug Resistant Epilepsy Through Glial-Cell-Line Derived Neurotrophic Factor (GDNF) And Interleukin 1ß (IL-1 ß) Modulation Pathway
试验速览
- 阶段
- 早期 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 70
- 试验地点
- 1
- 主要终点
- Percentage change of seizure frequency
研究概览
简要总结
The incident of epilepsy still very high in Indonesia, thus many patients become drug resistant epilepsy. As vitamin D has some anticonvulsant effect, the investigators want to study if an additional dose of vitamin D can help with the therapy responses.
详细描述
Specifically the investigators want to study about :
- Correlation between serum vitamin D levels and seizure frequency change after vitamin D treatment
- Correlation between serum GDNF levels and seizure frequency change after vitamin D treatment
- Correlation between serum Interleukin-1ß levels and seizure frequency change after vitamin D treatment
- Responder rate. Percentage of patients change of at least 50% of the seizure frequency
- Remission rate after vitamin D treatment. Percentage of patients without any seizure (seizure freedom)
- Effect of vitamin D according to epilepsy type. Responder rate in focal and generalized epilepsy.
- Effect on Global Assesment of the Severity of Epilepsy (GASE)
- Effect on Hague Seizure Severity scale (HASS)
- Effect on Quality of Life in Epilepsy in Children: (QOLCE 55)
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 1 Year 至 18 Years(Child, Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age 1 - 18 years
- •Drug-resistant epilepsy
- •Having at least 6 unprovoked seizures in the previous 3 months
- •No vitamin D treatment in the previous 6 months
- •Medication compliance
- •Agreeing to participate in the study
- •Having a social insurance
- •Parental agreement
排除标准
- •Treatments influencing the metabolism of vitamin D other than anticoagulants (rifamycin, isoniazid, ketoconazole, 5-FU fluorouracil, leucovorin)
- •Known hypersensitivity to vitamin D
- •Lost to follow up
研究组 & 干预措施
Vitamin D
DRE patients with proved vitamin D deficiency (Serum vitamin D level <30ng/ml). intervention: Daily Cholecalciferol 1000 IU in 24 weeks.
干预措施: Cholecalciferol (Drug)
Placebo
DRE patients with proved vitamin D deficiency (Serum vitamin D level <30ng/ml). Interventions: Daily Placebo oral (Manufactured to mimic Cholecalciferol) in 24 weeks.
干预措施: Placebo (Other)
结局指标
主要结局
Percentage change of seizure frequency
时间窗: 12 and 24 weeks
Change on number of seizure
次要结局
- Effect on Global Assessment of the Severity of Epilepsy (GASE)(12 and 24 weeks)
- Effect on Hague Seizure Severity scale (HASS)(12 and 24 weeks)
- Correlation between serum vitamin D levels and seizure frequency change after vitamin D treatment(12 and 24 weeks)
- Correlation between serum Interleukin-1ß levels and seizure frequency change after vitamin D treatment(12 and 24 weeks)
- Effect on Quality of Life in Epilepsy in Children: (QOLCE 55)(12 and 24 weeks)
- Correlation between serum GDNF levels and seizure frequency change after vitamin D treatment(12 and 24 weeks)
- Responder rate(12 and 24 weeks)
- Remission rate after vitamin D treatment(12 and 24 weeks)
- Effect of vitamin D according to epilepsy type(12 and 24 weeks)
研究者
DINA KEUMALA SARI
Sponsor-investigator
Universitas Sumatera Utara
